Detailed answers about PRIMARY EYECARE (AIREDALE, BRADFORD & LEEDS) LIMITED, including incorporation, status, business activity, and accounts information.
When was PRIMARY EYECARE (AIREDALE, BRADFORD & LEEDS) LIMITED founded?
PRIMARY EYECARE (AIREDALE, BRADFORD & LEEDS) LIMITED was officially incorporated on 8 November 2013 and is registered under company number 08767563. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is PRIMARY EYECARE (AIREDALE, BRADFORD & LEEDS) LIMITED?
PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital). This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of PRIMARY EYECARE (AIREDALE, BRADFORD & LEEDS) LIMITED?
PRIMARY EYECARE (AIREDALE, BRADFORD & LEEDS) LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does PRIMARY EYECARE (AIREDALE, BRADFORD & LEEDS) LIMITED do?
PRIMARY EYECARE (AIREDALE, BRADFORD & LEEDS) LIMITED operates in the following sector: 86900 - Other human health activities. This provides insight into the company's primary business activity and industry focus.
What is PRIMARY EYECARE (AIREDALE, BRADFORD & LEEDS) LIMITED's registered address?
The registered office address of PRIMARY EYECARE (AIREDALE, BRADFORD & LEEDS) LIMITED is 2 WOODBRIDGE STREET, LONDON, EC1R 0DG. This is the official address filed with Companies House for legal and statutory correspondence.
Is PRIMARY EYECARE (AIREDALE, BRADFORD & LEEDS) LIMITED financially stable?
The most recent accounts for PRIMARY EYECARE (AIREDALE, BRADFORD & LEEDS) LIMITED were made up to 30 November 2024, filed as DORMANT. Next accounts are due by 31 August 2026.